Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-017815
Filing Date
2025-07-03
Accepted
2025-07-03 16:15:47
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 350205
2 EX-5.1 ex5-1.htm EX-5.1 20198
3 EX-23.1 ex23-1.htm EX-23.1 4317
4 CALCULATION OF FILING FEE TABLES ex107.htm   iXBRL EX-FILING FEES 23009
5 GRAPHIC forms-3_001.jpg GRAPHIC 3379
6 GRAPHIC forms-3_002.jpg GRAPHIC 3379
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3441
  Complete submission text file 0001641172-25-017815.txt   533895

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5360
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288518 | Film No.: 251105756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)